bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
0.2800
+0.0061 (2.23%)
At close: Aug 13, 2025, 4:00 PM
0.2800
0.00 (0.00%)
After-hours: Aug 13, 2025, 6:34 PM EDT
bioAffinity Technologies Market Cap
bioAffinity Technologies has a market cap or net worth of $7.85 million as of August 13, 2025. Its market cap has decreased by -75.16% in one year.
Market Cap
7.85M
Enterprise Value
8.79M
1-Year Change
-75.16%
Ranking
Category
Stock Price
$0.28
Market Cap Chart
Since the IPO on September 1, 2022, bioAffinity Technologies's market cap has decreased from $45.03M to $7.85M, a decrease of -82.57%. That is a compound annual growth rate of -44.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 7.68M | -45.87% |
| Dec 31, 2024 | 14.18M | 1.50% |
| Dec 29, 2023 | 13.97M | 4.34% |
| Dec 30, 2022 | 13.39M | -70.26% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 570.26B |
| Johnson & Johnson | 418.62B |
| AbbVie | 350.91B |
| AstraZeneca | 229.47B |
| UnitedHealth Group | 228.94B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 228.63B |
| Novo Nordisk | 222.88B |